| Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study M Streitz, T Miloud, M Kapinsky, MR Reed, R Magari, EK Geissler, ... Transplantation research 2, 1-15, 2013 | 229 | 2013 |
| Age and gender leucocytes variances and references values generated using the standardized ONE‐Study protocol AH Kverneland, M Streitz, E Geissler, J Hutchinson, K Vogt, D Boës, ... Cytometry part A 89 (6), 543-564, 2016 | 103 | 2016 |
| Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer AH Kverneland, M Pedersen, MCW Westergaard, M Nielsen, TH Borch, ... Oncotarget 11 (22), 2092, 2020 | 83 | 2020 |
| CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer C Friese, K Harbst, TH Borch, MCW Westergaard, M Pedersen, ... Scientific reports 10 (1), 3914, 2020 | 67 | 2020 |
| Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab AH Kverneland, C Enevold, M Donia, L Bastholt, IM Svane, CH Nielsen Oncoimmunology 7 (5), e1424674, 2018 | 49 | 2018 |
| Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types AH Kverneland, CA Chamberlain, TH Borch, M Nielsen, SK Mørk, ... Journal for immunotherapy of cancer 9 (10), 2021 | 35 | 2021 |
| Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy CA Chamberlain, EP Bennett, AH Kverneland, IM Svane, M Donia, Ö Met Molecular Therapy-Oncolytics 24, 417-428, 2022 | 30 | 2022 |
| Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor … A Draghi, CA Chamberlain, S Khan, K Papp, M Lauss, S Soraggi, ... Frontiers in Immunology 12, 705422, 2021 | 15 | 2021 |
| Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles AH Kverneland, O Østergaard, KB Emdal, IM Svane, JV Olsen Proteomics 23 (7-8), 2200039, 2023 | 13 | 2023 |
| Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma TH Borch, K Harbst, AH Rana, R Andersen, E Martinenaite, P Kongsted, ... Journal for ImmunoTherapy of Cancer 9 (7), 2021 | 12 | 2021 |
| Proteomics to study cancer immunity and improve treatment G Franciosa, AH Kverneland, AWP Jensen, M Donia, JV Olsen Seminars in Immunopathology 45 (2), 241-251, 2023 | 5 | 2023 |
| TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy SA Tvingsholm, MS Frej, VM Rafa, UK Hansen, M Ormhøj, A Tyron, ... Journal for immunotherapy of cancer 11 (8), 2023 | 5 | 2023 |
| Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition AH Kverneland, TH Borch, J Granhøj, H Sengeløv, M Donia, IM Svane Cytotherapy 23 (8), 724-729, 2021 | 5 | 2021 |
| 1022MO Clinical potential of adoptive cell therapy with tumour infiltrating lymphocytes therapy in combination with checkpoint inhibitors in non-melanoma patients AH Kverneland, TH Borch, C Chamberlain, CL Lorentzen, M Nielsen, ... Annals of Oncology 31, S706, 2020 | 3 | 2020 |
| Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor induction in checkpoint inhibitor resistant metastatic melanoma patients TH Borch, R Andersen, MAH Rana, P Kongsted, M Pedersen, M Nielsen, ... Annals of Oncology 29, viii402, 2018 | 3 | 2018 |
| Evaluation of CPa9-HNE-a peripheral biomarker based on neutrophil extracellular traps (NETs)-for predicting outcome in patients with metastatic melanoma treated with anti-PD-1 … C Jensen, A Kverneland, M Donia, JH Mortensen, MA Karsdal, IM Svane, ... Cancer Research 81 (13_Supplement), 386-386, 2021 | 2 | 2021 |
| First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer SK Mørk, P Kongsted, MCW Westergaard, B Albieri, JS Granhøj, M Donia, ... Frontiers in Immunology 14, 1122977, 2023 | 1 | 2023 |
| Fully automated workflow for integrated sample digestion and Evotip loading enabling high-throughput clinical proteomics AH Kverneland, F Harking, JM Vej-Nielsen, M Huusfeldt, ... Molecular & Cellular Proteomics, 100790, 2024 | | 2024 |
| Biomarkers of response and acquired resistance to TIL-ACT in solid tumors W Robinson, A Castro, M Al-Bakir, JJ Gartner, CA Chamberlain, ... Cancer Research 84 (6_Supplement), 1-1, 2024 | | 2024 |
| 45P Protein biomarkers associated with organ-specific immune-related toxicity and response to management identified by proteome analysis of extracellular vesicles from plasma AH Kverneland, JE Jörn, IM Noringriis, RS Jurlander, O Østergaard, ... Immuno-Oncology and Technology 20, 2023 | | 2023 |
